“Inclisiran: Early LDL-C target achievement in a real-life population”
Background and objectives: Elevated low-density lipoprotein cholesterol (LDL-C) levels are associated with atherosclerotic cardiovascular diseases. Inclisiran, a small interfering RNA, has been observed to effectively and sustainably reduce LDL-C in large randomized controlled trials (RCTs); however...
Saved in:
Main Authors: | Francesco Briani, Mauro Bagli, Gabriele Venturi, Francesco Bacchion, Antonio Mugnolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Atherosclerosis Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266708952500001X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review
by: Nazia Afroze, et al.
Published: (2025-02-01) -
National Health Laboratory Service (NHLS) changes the method of LDL-cholesterol calculation in South Africa
by: T Pillay, et al.
Published: (2023-12-01) -
Blood Lipid Levels and Their Value as Markers of Disease Activity in Severe Ulcerative Colitis
by: Zhu L, et al.
Published: (2025-02-01) -
Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort
by: Tessa M. Zeis, MD, et al.
Published: (2025-03-01) -
PCSK9 affects vascular senescence through the SIRT1 pathway
by: Yuqin Wang, et al.
Published: (2025-03-01)